Clinical experience with ferric carboxymaltose in the treatment of cancer- and chemotherapy-associated anaemia

BACKGROUND: Intravenous (i.v.) iron can improve anaemia of chronic disease and response to erythropoiesis-stimulating agents (ESAs), but data on its use in practice and without ESAs are limited. This study evaluated effectiveness and tolerability of ferric carboxymaltose (FCM) in routine treatment o...

Descripción completa

Detalles Bibliográficos
Autores principales: Steinmetz, T., Tschechne, B., Harlin, O., Klement, B., Franzem, M., Wamhoff, J., Tesch, H., Rohrberg, R., Marschner, N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2013
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3551483/
https://www.ncbi.nlm.nih.gov/pubmed/23071262
http://dx.doi.org/10.1093/annonc/mds338

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3551483/
https://www.ncbi.nlm.nih.gov/pubmed/23071262
http://dx.doi.org/10.1093/annonc/mds338

Ejemplares similares